1. YM155 induces apoptosis in p53-deficient T-acute lymphoblastic leukemia cells independent of survivin inhibition
   Leilane Sales et al, 2017, Anti-Cancer Drugs CrossRef
2. miRNA‑218 targets multiple oncogenes and is a therapeutic target for osteosarcoma
   Kentaro Sato et al, 2022, Oncology Reports CrossRef
3. High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth
   Marieke A. de Graaff et al, 2017, Translational Oncology CrossRef
4. YM155 sensitizes TRAIL-induced apoptosis through cathepsin S-dependent down-regulation of Mcl-1 and NF-κB-mediated down-regulation of c-FLIP expression in human renal carcinoma Caki cells
   Seon Min Woo et al, 2016, Oncotarget CrossRef
5. Survivin expression modulates the sensitivity of A549 lung cancer cells resistance to vincristine
   Chengwei Zhou et al, 2018, Oncology Letters CrossRef
6. Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma
   Marta Mendiola et al, 2024, Biomedicine & Pharmacotherapy CrossRef